Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8194 ↗At a glance
Leserbrief in Phytotherapy Research, 2024. Written by Nader Aghakhani and 1 co-authors. Institution: Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran. Major MEDLINE topics: Curcumin, COVID-19 Drug Treatment, Complementary Therapies, Dietary Supplements. 24 references.
Abstract (original language)
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran.
- Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
- Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, Iran.
ORCID profiles: Hamid Soraya
Cite
APA
Aghakhani, N., & Soraya, H. (2024). Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients. Phytotherapy Research. https://doi.org/10.1002/ptr.8194
Vancouver
Aghakhani N, Soraya H. Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients. Phytotherapy Research. 2024. doi:10.1002/ptr.8194
BibTeX
@article{Aghakhani2024,
author = {Aghakhani, Nader and Soraya, Hamid},
title = {Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8194}
}
EUVIMED